SomnoMed Company Description

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region.

It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorning Repositioner, which help return mandible back to its pre-treatment centric position; and SomTabs for cleaning oral devices.

The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

SomnoMed Limited

Country	Australia
Founded	1987
Industry	Medical Devices
Sector	Healthcare

Contact Details

Address: 20 Clarke Street Crows Nest, NSW NSW Australia
Phone	61 2 9467 0400

Stock Details

Ticker Symbol	SOM
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000SOM1
SIC Code	3843

Key Executives

Name	Position
Karen Borg B.A.	Co-Chief Executive Officer and Executive Director
Amrita Blickstead BME, M.B.A.	Co-Chief Executive Officer and Executive Director
Ye-Fei Guo	Chief Financial Officer
Jonathan Vowels	Vice President of Manufacturing and Operations
David Lewis	Chief Information Officer
Nathan Minnich	Chief Marketing Officer
Janice Hiskett-Jones	Chief People Officer
Marco Van Kleef	President of Europe
Keshan Gunasinghe	Chief Product Officer
Greg Knight	Chief Transformation Officer